Hevosen merkitys yleisen liikkuvuus- ja kuljetusprobleemin ratkaisussa nykyisen organisaatiomme puitteissa

Johdannossa todetaan, että hevosen merkityksen selvittäminen vaatii ennakkoluulotonta ja kaikki aselajit sisältävän kokonaisvaltaisen tarkastelun. Toisessa luvussa tuodaan esille kokemuksia ja kehityksen nykyinen suunta. Osioon sisältyvän taulukon tarkastelu muun muassa osoittaa, että suhteellisesti enemmän hevosia oli saksalaisessa jalkaväkidivisioonassa. "Auto syrjäytti meillä hevosen täydennyskuljetusvälineenä pataljoonaportaasta ylöspäin jo talvisodan aikana." Seuraavassa luvussa tarkastelussa on hevosen tehtävät nykyisessä organisaatiossamme. Neljännessä luvussa tarkastellaan liikkuvuutta, käsitellen perusteita ja vaatimuksia, prikaatin perusliikkuvuutta ja sen muutoksia tiestön huonontuessa sekä materiaalista taisteluvalmiutta ja sen muuttumista. Johtopäätöksissä todetaan, että "Lyhyesti sanottuna prikaati tarvitsisi liikkuvuutensa lisäämiseksi autoteillä lisää autoja, kärryteillä traktoreita ja tiettömässä maastossa hevosia."Täydennyskuljetuksia käsittelevässä luvussa tarkastellaan johtopäätöksineen eri välineiden kuljetustehoa, kulutuksen suuruutta ja sen aiheuttamia kuljetuksia. Seuraavassa luvussa tarkastellaan maamme moottoriajoneuvo- ja hevoskantaa sekä niiden muutoksia. Viimeisessä luvussa vertaillaan eri kuljetusvälineitä ja niiden teknisiä ominaisuuksia sekä käsitellään talven ja tappioiden vaikutuksia. Loppupäätelmissä muun muassa todetaan, että hevoset tulee säilyttää prikaatin organisaatiossa maastokelpoisuuden ylläpitämiseksi

No SMAD4 hypermethylation in colorectal cancer

The chromosome region 18q21 is frequently deleted in colorectal cancers. Three candidate tumour suppressor genes, DCC, SMAD4 and SMAD2, map to this region. The SMAD4(DPC4) gene was recently identified as a candidate pancreatic cancer suppressor gene. It is also a gene for juvenile polyposis tumour predisposition syndrome. Somatic SMAD4 mutations have been detected in some colorectal carcinomas. However, the frequency of these mutations is relatively low, and whether SMAD4 plays a key role in colorectal tumorigenesis is still unclear. In addition to loss of chromosomal material and intragenic mutations there is a third mechanism, DNA methylation, which may have an important role in gene inactivation. In the present study, we examined whether promoter hypermethylation could be a mechanism for SMAD4 inactivation. In total, 42 colorectal tumours were selected for the methylation analysis and no evidence of promoter hypermethylation was found. Our result suggests that hypermethylation of the SMAD4 promoter region is not a frequent event in colorectal tumorigenesis. © 2000 Cancer Research Campaig

Mental Wellbeing:Future Agenda Drawing from Design, HCI and Big Data

Most HCI work on the exploration and support of mental wellbeing involves mobiles, sensors, and various on-line systems which focus on tracking users. However, adoption of, and adherence to such systems is not ideal. Are there innovative ways to better design for mental wellbeing? A promising novel approach is to encourage changes to behavior through the use of tailored feedback informed by machine learning algorithms applied to large sets of use data. This one day workshop aims to explore novel ways to actively engage participants through interactive systems, with an overall aim to shape the research agenda of future HCI work on mental wellbeing. The workshop is designed in an innovative format offering a mixture of traditional presentation, hands-on design and future-thinking activities. The workshop brings together both practitioners and HCI researchers from across a range areas addressing mental wellbeing

Vitamin D with Calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials

Introduction: Vitamin D may affect multiple health outcomes. If so, an effect on mortality is to be expected. Using pooled data from randomized controlled trials, we performed individual patient data (IPD) and trial level meta-analyses to assess mortality among participants randomized to either vitamin D alone or vitamin D with calcium. Subjects and Methods: Through a systematic literature search, we identified 24 randomized controlled trials reporting data on mortality in which vitamin D was given either alone or with calcium. From a total of 13 trials with more than 1000 participants each, eight trials were included in our IPD analysis. Using a stratified Cox regression model, we calculated risk of death during 3 yr of treatment in an intention-to-treat analysis. Also, we performed a trial level meta-analysis including data from all studies. Results: The IPD analysis yielded data on 70,528 randomized participants (86.8% females) with a median age of 70 (interquartile range, 62–77) yr. Vitamin D with or without calcium reduced mortality by 7% [hazard ratio, 0.93; 95% confidence interval (CI), 0.88–0.99]. However, vitamin D alone did not affect mortality, but risk of death was reduced if vitamin D was given with calcium (hazard ratio, 0.91; 95% CI, 0.84–0.98). The number needed to treat with vitamin D plus calcium for 3 yr to prevent one death was 151. Trial level meta-analysis (24 trials with 88,097 participants) showed similar results, i.e. mortality was reduced with vitamin D plus calcium (odds ratio, 0.94; 95% CI, 0.88–0.99), but not with vitamin D alone (odds ratio, 0.98; 95% CI, 0.91–1.06). Conclusion: Vitamin D with calcium reduces mortality in the elderly, whereas available data do not support an effect of vitamin D alone

POSIWID and determinism in design for behaviour change

Copyright @ 2012 Social Services Research GroupWhen designing to influence behaviour for social or environmental benefit, does designers' intent matter? Or are the effects on behaviour more important, regardless of the intent involved? This brief paper explores -- in the context of design for behaviour change -- some treatments of design, intentionality, purpose and responsibility from a variety of fields, including Stafford Beer's "The purpose of a system is what it does" and Maurice Broady's perspective on determinism. The paper attempts to extract useful implications for designers working on behaviour-related problems, in terms of analytical or reflective questions to ask during the design process

The design with intent method: A design tool for influencing user behaviour

The official published version can be found at the link below.Using product and system design to influence user behaviour offers potential for improving performance and reducing user error, yet little guidance is available at the concept generation stage for design teams briefed with influencing user behaviour. This article presents the Design with Intent Method, an innovation tool for designers working in this area, illustrated via application to an everyday human–technology interaction problem: reducing the likelihood of a customer leaving his or her card in an automatic teller machine. The example application results in a range of feasible design concepts which are comparable to existing developments in ATM design, demonstrating that the method has potential for development and application as part of a user-centred design process

Theorizing dramaturgical resistance leadership from the leadership campaigns of Jeremy Corbyn

What are the practices through which resistance leadership transitions from marginality to power? We present a framework of dramaturgical resistance leadership, paying particular attention to the relational dynamics between leaders, internal factions and external stakeholders. In doing so, we draw on an ‘expanded’ social drama analysis framework informed by the work of social anthropologist Victor Turner, incorporating insights from the resistance and critical leadership studies literatures. We develop our framework through a narrative case analysis of the British Labour Party’s 2015 and 2016 internal elections of its current leader Jeremy Corbyn where we identify a space between the phases of relational crisis and redress that offers possibilities for the enhancement and growth of resistance leadership. Within this space, we identify three practices of dramaturgical resistance leadership: ‘anti-establishment leadering’, ‘organizational redrawing’, and a ‘trifold focus’. These offer a means of rethinking the purpose and role of leaders within resistance movements alongside the co-constituted relations and generative practices that enable resisting groups to gain traction

EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis

BACKGROUND: Ephrin receptor B2 (EPHB2) has recently been proposed as a novel tumor suppressor gene in colorectal cancer (CRC). Inactivation of the gene has been shown to correlate with progression of colorectal tumorigenesis, and somatic mutations have been reported in both colorectal and prostate tumors. METHODS: Here we have analyzed the EPHB2 gene for germline alterations in 101 individuals either with 1) CRC and a personal or family history of prostate cancer (PC), or 2) intestinal hyperplastic polyposis (HPP), a condition associated with malignant degeneration such as serrated adenoma and CRC. RESULTS: Four previously unknown missense alterations were observed, which may be associated with the disease phenotype. Two of the changes, I361V and R568W, were identified in Finnish CRC patients, but not in over 300 Finnish familial CRC or PC patients or more than 200 population-matched healthy controls. The third change, D861N, was observed in a UK HPP patient, but not in additional 40 UK HPP patients or in 200 UK healthy controls. The fourth change R80H, originally identified in a Finnish CRC patient, was also found in 1/106 familial CRC patients and in 9/281 healthy controls and is likely to be a neutral polymorphism. CONCLUSION: We detected novel germline EPHB2 alterations in patients with colorectal tumors. The results suggest a limited role for these EPHB2 variants in colon tumor predisposition. Further studies including functional analyses are needed to confirm this

Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers

Germline mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene were recently identified in individuals with pituitary adenoma predisposition (PAP). These patients have prolactin (PRL) or growth hormone (GH) oversecreting pituitary adenomas, the latter exhibiting acromegaly or gigantism. Loss-of-heterozygosity (LOH) analysis revealed that AIP is lost in PAP tumours, suggesting that it acts as a tumour-suppressor gene. Aryl hydrocarbon receptor interacting protein is involved in several pathways, but it is best characterised as a cytoplasmic partner of the aryl hydrocarbon receptor (AHR). To examine the possible role of AIP in the genesis of common cancers, we performed somatic mutation screening in a series of 373 colorectal cancers (CRCs), 82 breast cancers, and 44 prostate tumour samples. A missense R16H (47G>A) change was identified in two CRC samples, as well as in the respective normal tissues, but was absent in 209 healthy controls. The remaining findings were silent, previously unreported, changes of the coding, non-coding, or untranslated regions of AIP. These results suggest that somatic AIP mutations are not common in CRC, breast, and prostate cancers

Comparison of published orthopaedic trauma trials following registration in Clinicaltrials.gov

<p>Abstract</p> <p>Background</p> <p>After the Food and Drug Administration Modernization Act of 1997, the registration of all clinical trials became mandatory prior to publication. Our primary objective was to determine publication rates for orthopaedic trauma trials registered with ClinicalTrials.gov. We further evaluated methodological consistency between registration and publication.</p> <p>Methods</p> <p>We searched Clinical Trials.gov for all trials related to orthopaedic trauma. We excluded active trials and trials not completed by July 2009, and performed a systematic search for publications resulting from registered closed trials. Information regarding primary and secondary outcomes, intervention, study sponsors, and sample size were extracted from registrations and publications.</p> <p>Results</p> <p>Of 130 closed trials, 37 eligible trials resulted in 16 publications (43.2%). We found no significant differences in publication rates between funding sources for industry sponsored studies and nongovernment/nonindustry sponsored studies (<it>p </it>> 0.05). About half the trials (45%) did not include the NCT ID in the publication. Two (10%) publications had major changes to the primary outcome measure and ten (52.6%) to sample size.</p> <p>Conclusions</p> <p>Registration of orthopaedic trauma trials does not consistently result in publication. When trials are registered, many do not cite NCT ID in the publication. Furthermore, changes that are not reflected in the registry of the trial are frequently made to the final publication.</p